Sign in
Flavopiridol methods and compositions for HIV therapy
Patent   Open access

Flavopiridol methods and compositions for HIV therapy

David H Price and Adrian M Senderowicz
United States Patent and Trademark Office
12/09/2003
pdf
Flavopiridol methods and compositions for HIV therapy517.75 kBDownloadView
PDM V1.0 Open Access

Abstract

Disclosed is the unexpected discovery that flavopiridol binds tightly to the transcription elongation factor, P-TEFb and dramatically inhibits its activity. As P-TEFb is required for HIV propagation and replication, this invention provides new methods, compositions and kits for the effective treatment of HIV infections and AIDS using flavopiridol, both alone and combination with other therapies.

Details

Metrics

14 File views/ downloads
8 Record Views